In colon cancer, the expression of MYC has been shown to be increased, irrespective of tumour stage, and correlates with the expression of 231 unique metabolic genes,12 especially in glycolysis, the pentose phosphate pathway, the purine and pyrimidine biosynthesis pathway, some genes involved in fatty acid biosynthesis and one-carbon metabolism, as well as some metabolite transporters. Here, MYC is linked to neoplasm.